Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens
US11555078B2 · kind B2 · utility
0Cited by
20References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2021 |
| Grant date | Jan 17, 2023 |
| Priority date | — |
| Expiry date | Dec 7, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/70
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided herein are multispecific antibodies that selectively bind to PSMA and effector cell antigens such as CD3, pharmaceutical compositions thereof, as well as nucleic acids, and methods for making and discovering the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.